← Open Payments lookup

GAEA POPE-DAUM: Open Payments

NPI 1679878193 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$462 in 18 payments from 9 companies in 2025. Trend: 2023 $332 · 2024 $1,837 · 2025 $462

Food & beverage: $462
CompanyPaymentsAmount
Tris Pharma Inc5$117
Takeda Pharmaceuticals U.S.A., Inc.4$96
Neurocrine BioSciences, Inc.2$59
Axsome Therapeutics, Inc.2$55
Janssen Pharmaceuticals, Inc1$39
Sage Therapeutics, LLC1$28
MERZ NORTH AMERICA, INC.1$26
ABBVIE INC.1$23
bioMerieux Inc1$20

Products named: Dyanavel XR, TRINTELLIX, INGREZZA, Auvelity, INVEGA SUSTENNA, ZURZUVAE, Xeomin, VRAYLAR.

Industry payments across CA — which companies pay providers there.